Pillstats
Rx only · Injection, Solution, Concentrate · Intravenous

Dexmedetomidine

Dexmedetomidine Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)48937
US makers3 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1833655487302025 Q12025 Q22025 Q32025 Q42026 Q1
134
Rx · 2026 Q1
226
Units dispensed
-74%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
WG Critical Care, LLCunknown2SUPPLYING
Mylan Institutional LLCunknown1SUPPLYING
Avenacy, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 10, 2020
    SHORTAGEDrug shortage: Dexmedetomidine Hydrochloride Injection (HQ Specialty Pharma)

    Dexmedetomidine Hydrochloride Injection — reported in shortage by HQ Specialty Pharma. Therapeutic category: Anesthesia.

  • Apr 10, 2020
    SHORTAGEDrug shortage: Dexmedetomidine Hydrochloride Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Dexmedetomidine Hydrochloride Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Anesthesia.